Milestone Reached for SGLT2 Inhibitor Aimed at Heart Attack Population Good signals in people with large acute MIs at risk of developing heart failure Aug 30, 2022
Transradial Access for Heart Procedures Saves Lives in Most Definitive Study Yet Approach beats coronary access through the thigh Aug 29, 2022
Doubling Up on Heart Drugs May Delay Aortic Damage From Marfan Syndrome Meta-analysis settles the confusion around angiotensin receptor blockers Aug 29, 2022
Finally, A Foundational Heart Failure Drug That Works Across the Spectrum of EF SGLT2 inhibitor shines in landmark DELIVER trial Aug 27, 2022
ADVOR Backs Add-On Acetazolamide for Cutting Congestion in Decompensated HF Exclusion of patients on SGLT2 inhibitors was a major trial limitation, expert says Aug 27, 2022
PCI Flops for Ischemic LV Dysfunction With Coronary Artery Disease Randomized trial provides "definitive" evidence against revascularizing stable cases Aug 27, 2022
Mass Cardiovascular Testing May Add Years for Some Men Mixed results after the DANCAVAS program from Denmark Aug 27, 2022
No Detrimental Impact on Cognition With Entresto for Heart Failure Cost may be reason for underutilization, rather than concerns about cognition, expert noted Aug 26, 2022
No Worsening Cardiac Dysfunction in Long COVID Other harms likely contribute to dyspnea, HF after COVID-19 hospitalization Aug 05, 2022
Heart Disease Will Surge Over the Coming Decades Worsening racial disparities are also projected Aug 01, 2022
Heart Defects Tend to Accompany Penis Abnormality at Birth Prevalence is several times higher among boys with hypospadias, study showed Jul 29, 2022
Fluid Therapy Showdown in Cardiac Surgery Disfavors Albumin Major adverse events not reduced, and some complications increased Jul 19, 2022
Paxlovid-Heart Drug Interactions; Turkish Cardiologist Murdered; Permanent PCSK9i? Recent developments of interest in cardiovascular medicine Jul 12, 2022
Bye-Bye, 'Life's Simple 7': AHA Redefines Cardiovascular Health by Adding Sleep New metrics and scoring algorithm for heart health in children and adults Jun 29, 2022
Which Advanced HF Patients Are Entresto-Intolerant in the Real World? 1 in 6 dropped out from the LIFE trial because of side effects Jun 27, 2022
Hearts in Extreme Heat; Pandemic's Heart Transplant Policies; Entresto Titration Recent developments of interest in cardiovascular medicine Jun 21, 2022
Heart Failure Drugs Can Be Unaffordable on Medicare, Study Finds Older adults are subject to cost-sharing and other medication coverage restrictions Jun 21, 2022
No Early Cardiovascular Risks With Testosterone Treatment Data on long-term safety needed, however Jun 13, 2022
TAVR Pacemaker Rate Dips to Single Digits Nationwide, but Outlier Hospitals Remain Do worst-performing sites need more education about best practices? Jun 12, 2022
Fate of Transcatheter Tricuspid Devices: Will it Be Repair or Replacement? Many unanswered questions remain regarding devices for tricuspid regurgitation Jun 11, 2022
TAVR Devices Keep Changing -- Is This Really Helping Patients? Clinical outcomes are headed in the right direction, but better research is needed Jun 10, 2022
Good News for Heart Failure Patients Getting COVID Booster Shots Group saw lower risks for hospitalization, ICU admission, death versus the unvaccinated Jun 09, 2022
Promising First Dips Into a Bigger Pool of MitraClip Candidates Real-world outcomes in people with secondary MR who don't fit COAPT criteria Jun 09, 2022
SGLT2 Inhibitors a Better First Drug in Type 2 Diabetes Than Metformin? Observational study suggests some cardiovascular benefit May 23, 2022
TAVR for Aortic Regurgitation Off to a Good Start in the Real World Yet some growing pains remain for the Jenavalve Trilogy May 21, 2022
No-Implant Shunt Eases HF Symptoms in Early Data Quality of life consistently improved across first-in-man studies May 20, 2022
Device Type Matters for Valve-in-Valve TAVR in Small Anatomies Showdown between Sapien and Evolut valves in the LYTEN trial May 20, 2022
Harmony Pulmonary Valves 'Behaving' at 1 Year Pooled study data show no mortality, favorable clinical outcomes May 20, 2022
TAVR Stays Its Course as 10-Year Durability Data Trickle In Glimpse of longer-term valve degeneration in early TAVR patients May 19, 2022
Do Pediatric Electrophysiologists Have It Harder? Clinicians discuss the dilemmas and shortcomings in the field May 02, 2022
Cardiac Myosin Inhibitor Gets FDA's Blessing for Obstructive HCM First-in-class mavacamten will be subject to REMS, however Apr 29, 2022
In These Patients, NT-proBNP Underestimates Heart Failure Risk Is it time for sex- and race-specific risk thresholds? Apr 27, 2022
Even With CKD, Patiromer Helped Heart Failure Patients Keep Hyperkalemia at Bay Promising findings from prespecified renal analysis of the DIAMOND trial Apr 09, 2022
Systemic Corticosteroids in Acute HF: Worth Another Look? Some see a potential treatment for patients with more inflammation Apr 08, 2022
Stroke While on LVAD No Barrier to Successful Heart Transplant It doesn't help, for sure, but it doesn't seem to hurt greatly either Apr 05, 2022
TAVR Valve Outlasts Surgical Bioprostheses at 5 Years No longer assume that TAVR bioprostheses are inherently less durable Apr 05, 2022
Patiromer Limits Impact of RAAS Inhibitor-Related Hyperkalemia in HF Patients better able to achieve target dose of mineralocorticoids and angiotensin inhibitors Apr 04, 2022
Transcatheter Tricuspid Repair Shows Early Promise PASCAL device safe and linked to symptom improvement in severe tricuspid regurgitation Apr 04, 2022
Flu Vaccine Didn't Stop Vascular Events in Heart Failure Patients But study in lower income countries sees hint of benefit during peak disease season Apr 04, 2022
